US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist
  • 4.3000
  • -0.2300-5.08%
Close Nov 27 16:00 ET
  • 4.3000
  • 0.00000.00%
Post 20:01 ET
3.09MMarket Cap-560P/E (TTM)

InMed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

InMed Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q31.601M / 2.005M--
--2024/Q21.682M / 1.518M--
--2024/Q11.243M / 1.895M--
--2023/Q43.126M / 3.039M--
Sep 23, 20222022/Q4698.290K / 969.890K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q31.601M / 2.005M--
--2024/Q21.682M / 1.518M--
--2024/Q11.243M / 1.895M--
--2023/Q43.126M / 3.039M--
Sep 23, 20222022/Q4698.290K / 969.890K--

Unlock Free Earnings Estimates

InMed Pharmaceuticals Earnings Reports

  • InMed Pharmaceuticals | 8-K: InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update

    Nov 15 11:28 ET

  • InMed Pharmaceuticals | 10-Q: Q1 2025 Earnings Report

    Nov 14 16:22 ET

  • InMed Pharmaceuticals | 10-K: FY2024 Annual Report

    Sep 30 12:40 ET

  • InMed Pharmaceuticals | 8-K: InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update

    May 14 16:24 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data